All In Biotech

Drug Trial Radar · NCT06846554

A Trial of "APL-9796'' in Adults With Pulmonary Hypertension

A Phase 2, Multicentre, Open-Label Trial to Evaluate APL-9796 in Adult Participants With Pulmonary Hypertension (ViTAL-PH)

Last checked: Nov 19, 2026Latest source record: May 11, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

48

Planned (sponsor's estimate)

Start

Apr 9, 2025

Primary completion

Aug 30, 2027

Study completion Sep 30, 2027

Sponsor

Lead sponsor
Apollo Therapeutics LtdIndustry
Sponsor type
Industry
First posted
Feb 26, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Non randomized
Model
Sequential
Masking
None
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 18 years, up to 80 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The AP13CP02 study is a phase 2, open-label, dose escalation trial to determine how safe and tolerable multiple subcutaneous (SC) injections of APL-9796 are for patients with PH. The study will also assess how effective APL-9796 could be for treating patients with PH and whether the body produces antibodies working against APL-9796. The trial will be conducted in two parts: * Part A: Up to 36 adults with WHO Group 1 Pulmonary arterial hypertension (PAH). * Part B (optional): Up to 12 adults with WHO Group 3 - PH associated with ILD (PH-ILD).

Conditions

  • Pulmonary Arterial Hypertension

Interventions

  • APL-9796Drug

    3 Cohorts are planned in Part A.

  • APL-9796Drug

    The decision to initiate optional Part B in WHO Group 3 PH-ILD participants will be made by the Safety Review Committee (SRC).

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Incidence of Treatment-Emergent Adverse Events [Safety and Tolerability]Time frame: Through study completion (approximately 2 years)

Locations

6 sites in 1 country. Site status is shown where the registry gives one.

  • Royal United Hospital Bath

    Bath, United Kingdom · Recruiting

  • Royal Papworth Hospital

    Cambridge, United Kingdom · Recruiting

  • Golden Jubilee Hospital

    Clydebank, United Kingdom · Recruiting

  • Royal Brompton Hospital

    London, United Kingdom · Recruiting

  • Sheffield Teaching Hospitals

    Sheffield, United Kingdom · Recruiting

  • Hammersmith/Imperial Hospital

    London, London, United Kingdom · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.